Inhibition of renin-angiotensin system (RAS) activity using angiotensin-converting enzyme
inhibitors or angiotensin II receptor blockers (ARBs) is beneficial in patient populations with …

Soluble CD40 ligand (sCD40L) is involved in the pathogenesis of risk factor-related vascular
damage and has been regarded as a molecular link between inflammation, thrombosis and …

Renal dysfunction is an independent risk factor for cardiovascular (cv) disease and its
associated complications. diabetes mellitus (dm) is a common cause of renal dysfunction …

Aims: This was a noninferiority study to evaluate whether the ARB telmisartan was not
inferior to the ACE inhibitor ramipril, and whether a combination of the two drugs was …

Despite proven renoprotection from RAAS blockade and its increased application since the
early 1990s, we have experienced an increasing CKD/ESRD epidemic, especially among …

Aggressive inhibition of renin–angiotensin–aldosterone system may provide the best
cardiovascular protection. We examined the effect of different doses of angiotensin II …

Heart failure (HF) is a major public health problem in the United States, and its prevalence is
likely to increase with the aging US population. Mechanical circulatory support (MCS) …

In Brief Cardiovascular disease (CVD) is a common complication of diabetes; nearly 80% of
all people with diabetes will die from macrovascular complications. Dyslipidemia …

Background: Trials evaluating angiotensin‐receptor blockers in heart failure (HF) have
shown inconsistent results. Objective: To evaluate the effect of angiotensin II (AII) receptor …

Despite of vast improvements in treatment, myocardial infarction often leads to heart failure
(HF) which remains the leading cause of death in developed countries. Other than heart …